Alentis Therapeutics
Leadership & Board
Key Executives
CEOAndrea Pellacani
CEORoberto Iacone
Chief Executive OfficerMark Pruzanski
Chief Business OfficerRizwan Velji
Current Number of Employees67
Current LinkedIn Followers13,774
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$181M
Total Amount Raised$181M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$181M
Latest Funding Amount$181M
Latest Funding RoundSeries D
Latest Funding RoundSeries D
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Alentis Therapeutics had 67 employees as of April 6, 2026. The number of employees increased by 0 (0.00%) week-over-week.
67Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Alentis Therapeutics had 13,774 followers as of April 6, 2026. The number of followers increased by 109 (0.80%) week-over-week.
13,774Latest Followers Count
109(0.80%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Funding Round
Aug 14, 2025
Series D
$181.40M
―
Investors
Series D
